Abstract:OBJECTIVE:To review the senescent remodeling of the immune system with aging and its relevance to the increased susceptibility of the elderly to infectious diseases, along with an outlook on emerging immunological biomarkers.DATA SOURCES:The data selected were from PubMed with relevant published articles in English or French from 1995 to the present. Searches were made using the terms "immunosenescence" and "aging" paired with the following: "innate immunity", "T-cell", "B-cell", "adaptive immunity" and "biomarkers". Articles were reviewed for additional citations and some information was gathered from web searches.STUDY SELECTION:Articles on aging of both the innate and adaptive immunity were reviewed, with special attention to the remodeling effect on the ability of the immune system to fight infectious diseases. Articles related to biomarkers of immunosenescence were selected with the goal of identifying immunological biomarkers predisposing the elderly to infections.RESULTS:Innate immunity is generally thought to be relatively well preserved or enhanced during aging compared with adaptive immunity which manifests more profound alterations. However, evidence, particularly in the last decade, reveals that both limbs of the immune system undergo profound remodeling with aging. Reported data on adaptive immunity is consistent and changes are well established but conflicting results about innate immunity were reported between in vivo and in vitro studies, as well as between murine and human studies. Epidemiological data suggests increased predisposition of the elderly to infections, but no compelling scientific evidence has directly linked senescent immune remodeling to this increased susceptibility. Recently, growing interest in identifying immunological biomarkers and defining "immune risk phenotypes/profiles" (IRP) has been expressed. Identification of biomarkers is in its early days and few potential biomarkers have been identified, with the Swedish having defined one IRP based on the adaptive immune response.CONCLUSIONS:Aging does not necessarily lead to an unavoidable decline in immune functions. Instead, a complex remodeling occurs. Despite the lack of compelling scientific evidence, senescent immune remodeling surely is a significant contributing factor to the increased risk and severity of infections in the elderly. Although, no immunological biomarker has been formally linked to the increased risk of infections in the elderly, biomarkers remain a promising tool to predict the likelihood of healthy aging, the level of immune competence, and mortality risk in the elderly. Hence, more research is required to define healthy aging and identify immunological biomarkers.

Insights into Vaccines for Elderly Individuals: from the Impacts of Immunosenescence to Delivery Strategies

Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly

Optimising vaccine immunogenicity in ageing populations: key strategies

Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors

How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells

Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives

Novel Technologies to Improve Vaccines for Older Adults

Vaccines for the Elderly and Vaccination Programs in Europe and the United States

Vaccination for healthy aging

Vaccinations in older adults: Optimization, strategies, and latest guidelines

Immune Alterations with Aging: Mechanisms and Intervention Strategies

Interaction of Aging and Immunosenescence: New Therapeutic Targets of Aging

Aging and Microbiome in the Modulation of Vaccine Efficacy

Vaccination programs for older adults in an era of demographic change

Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population

Senescent Remodeling of the Immune System and Its Contribution to the Predisposition of the Elderly to Infections.

The Impact of Immune System Aging on Infectious Diseases

Respiratory Syncytial Virus Vaccines: Analysis of Pre-Marketing Clinical Trials for Immunogenicity in the Population over 50 Years of Age

Immunosenescence: A new direction in anti-aging research

Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention

Multiple vaccine comparison in the same adults from the VITAL study reveals vaccine-specific and age-related humoral response patterns